QNTIX
Price
$40.42
Change
+$0.22 (+0.55%)
Updated
Jul 31 closing price
Net Assets
44.75M
RGWBX
Price
$29.76
Change
+$0.31 (+1.05%)
Updated
Jul 31 closing price
Net Assets
28.22B
Interact to see
Advertisement

QNTIX vs RGWBX

QNTIX vs RGWBX Comparison Chart in %
View a ticker or compare two or three
VS
QNTIX vs. RGWBX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QNTIX is a Buy and RGWBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGWBX has more cash in the bank: 28.2B vs. QNTIX (44.7M). QNTIX pays higher dividends than RGWBX: QNTIX (0.70) vs RGWBX (0.00). QNTIX was incepted earlier than RGWBX: QNTIX (10 years) vs RGWBX (14 years). QNTIX (1.55) is less costly to investors than RGWBX (1.46). QNTIX is a more actively managed with annual turnover of: 170.00 vs. RGWBX (1.00). RGWBX has a lower initial minimum investment than QNTIX: RGWBX (250) vs QNTIX (1000000). RGWBX annual gain was more profitable for investors over the last year : 10.02 vs. QNTIX (7.71). RGWBX return over 5 years is better than : 16.76 vs. QNTIX (-1.01).
QNTIXRGWBXQNTIX / RGWBX
Total Expense Ratio1.551.46106%
Annual Report Gross Expense Ratio1.551.46106%
Fund Existence10 years14 years-
Gain YTD6.3417.98379%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets44.7M28.2B0%
Annual Yield % from dividends0.700.00-
Returns for 1 year7.7110.0277%
Returns for 3 years15.4544.5935%
Returns for 5 years-1.0116.76-6%
Returns for 10 yearsN/A99.90-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LMUB49.66-0.05
-0.10%
iShares Long-Term National Muni Bd ETF
MIG20.92-0.06
-0.27%
VanEck IG Corporate ETF
HOLA56.05-0.20
-0.36%
JPMorgan Intl Hdg Eq Ldrd Overlay ETF
BTZ9.97-0.05
-0.50%
BlackRock Credit Allocation Income Trust
IDNA32.33-0.46
-1.40%
iShares Genomics Immnlgy & Hlthcr ETF